Covered recipient · General Payments record
JUAN GOYANES-VASQUEZ
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2024
$2,542.59
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,051.54 | 14 |
| Travel and Lodging | $849.77 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| LivaNova USA, Inc. | $1,429.28 | 6 |
| UCB, Inc. | $154.49 | 3 |
| SK Life Science, Inc. | $149.81 | 5 |
| Medtronic, Inc. | $131.57 | 1 |
| CSL Behring | $20.98 | 1 |
| ARGENX US, INC. | $15.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ARGENX US, INC. | $15.18 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142118159 | CMS |
| CSL Behring | $20.98 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134622199 | CMS |
| LivaNova USA, Inc. | $140.73 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152797545 | CMS |
| LivaNova USA, Inc. | $341.48 | 10/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152797679 | CMS |
| LivaNova USA, Inc. | $368.95 | 10/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152797681 | CMS |
| LivaNova USA, Inc. | $139.34 | 10/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152797683 | CMS |
| LivaNova USA, Inc. | $149.08 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152797685 | CMS |
| LivaNova USA, Inc. | $289.70 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152797687 | CMS |
| Medtronic, Inc. | $131.57 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119509135 | CMS |
| SK Life Science, Inc. | $109.33 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154123063 | CMS |
| SK Life Science, Inc. | $8.24 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154123095 | CMS |
| SK Life Science, Inc. | $9.12 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154123129 | CMS |
| SK Life Science, Inc. | $17.12 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154123137 | CMS |
| SK Life Science, Inc. | $6.00 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154123183 | CMS |
| UCB, Inc. | $16.11 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143284521 | CMS |
| UCB, Inc. | $125.00 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143284525 | CMS |
| UCB, Inc. | $13.38 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143284530 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.